NovaBridge Biosciences NBP
0.88 USD -0.02 (-2.58%)
Regular-session close
0.90 +0.02 +2.30%
After hours · Nov 19, 5:40 PM ET
0.85 Day range 0.9033
0.751 52-week range 5.19
- YTD
- -77.89%
- 1 year
- -80.58%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -94.27M | -51.43M | -72.02M | -53.08M | -276.13M | |
| -46.27M | -22.23M | -207.73M | -371.05M | -323.83M | |
| -0.483 | -0.276 | -2.51 | -4.51 | -4.27 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 210.63M | 68.26M | 291.51M | 459.83M | 489.39M | |
| 260.52M | 212.68M | 368.92M | 565.79M | 777.94M | |
| 29.58M | 11.52M | 126.34M | 161.63M | 144.67M | |
| 3.07M | 3.88M | 3.89M | 10.41M | 15.62M | |
| 230.94M | 201.16M | 242.58M | 404.15M | 633.27M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -20.60M | -80.17M | -182.49M | -166.25M | -135.15M | |
| 104.97M | -158.30M | 10.91M | 68.04M | -101.00M | |
| 57.73M | -4.51M | 1.67M | 6.72M | 82.49M | |
| 40.00K | 14.00K | -164.00K | -2.09M | -4.16M | |
| 142.37M | -242.40M | -164.70M | -77.30M | -171.55M |
